Company Filing History:
Years Active: 2007-2024
Title: Innovations of Shuhong Li: Advancements in Polymer Microfilters
Introduction
Shuhong Li, an inventive mind located in North Potomac, MD, has made significant contributions to the field of biomedical engineering through his innovative patents. With a total of three registered patents, his work has been instrumental in advancing technologies related to microfiltration and cellular analysis.
Latest Patents
Among his latest patents, Shuhong Li has developed advanced polymer microfilters aimed at the size-based capture and analysis of cells, particularly circulating cancer cells from whole blood and other human fluids. These microfilters feature a hydrophilic surface, making them ideal for various applications in medical diagnostics. The innovative filter material is photo-definable, allowing for the precision formation of pores using UV lithography. Notably, exemplary embodiments of his work also present devices that integrate microfilters with 3D nanotopography in culture scaffolds. This technology aims to replicate the 3D in vivo environment, greatly facilitating the growth of captured cells, which is a crucial aspect of research and therapeutic applications.
Career Highlights
Shuhong Li is currently associated with Creatv Microtech, Inc., where he continues to push the boundaries of innovation in his field. His work not only illustrates his technical expertise but also his commitment to improving patient outcomes through more effective cancer diagnostics and treatment methodologies.
Collaborations
Throughout his career, Shuhong has collaborated with notable colleagues such as Cha-Mei Tang and Olga V Makarova. These partnerships have fostered a rich exchange of ideas and have been pivotal in the development of groundbreaking technologies within the biomedical sector.
Conclusion
In summary, Shuhong Li's contributions through his patents and collaborations exemplify the drive for innovation in the field of biotechnology. His work with polymer microfilters stands to make a significant impact on how we approach cancer detection and analysis in clinical settings, paving the way for future advancements in medical technology.